Serum amyloid A enhances plasminogen activation: Implication for a role in colon cancer

Biochemical and Biophysical Research Communications

Volumn 368, Issue 2, 2008, Pages 368-373

  Michaeli, Amit ^a   Finci Yeheskel, Zvezdana ^a   Dishon, Shira ^a   Linke, Reinhold P ^b   Levin, Mark ^a   Urieli Shoval, Simcha ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Reference Center of Amyloid Diseases   (Germany)

Author keywords

HT 29 cells; Plasminogen activation; Serum amyloid A; Urokinase plasminogen activator

Indexed keywords

ACUTE PHASE PROTEIN; CHROMOGENIC SUBSTRATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLASMINOGEN; SERUM AMYLOID A; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CELL STRAIN HT29; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; FIBRINOLYSIS; HUMAN; HUMAN CELL; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

COLONIC NEOPLASMS; HT29 CELLS; HUMANS; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATORS; SERUM AMYLOID A PROTEIN;

EID: 39649118624     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.079     Document Type: Article

References (26)

1. Urieli-Shoval S., Linke R.P., and Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7 (2000) 64-69
2. Meek R.L., Urieli-Shoval S., and Benditt E.P. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA 91 (1994) 3186-3190
3. Urieli-Shoval S., Cohen P., Eisenberg S., and Matzner Y. Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J. Histochem. Cytochem. 46 (1998) 1377-1384
4. Gutfeld O., Prus D., Ackerman Z., Dishon S., Linke R.P., Levin M., and Urieli-Shoval S. Expression of serum amyloid A, in normal, dysplastic and neoplastic human colonic mucosa: Implication for a role in colonic tumorigenesis. J. Histochem. Cytochem. 54 (2006) 63-74
5. Badolato R., Wang J.M., Murphy W.J., Lloyd A.R., Michiel D.F., Bausserman L.L., Kelvin D.J., and Oppenheim J.J. Serum amyloid A is a chemoattractant: induction of migration, adhesion and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180 (1994) 203-209
6. Migita K., Kawabe Y., Tominaga M., Origuchi T., Aoyagi T., and Eguchi K. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab. Invest. 78 (1998) 535-539
7. Lee H.Y., Kim M.K., Park K.S., Bae Y.H., Yun J., Park J.I., Kwak J.Y., and Bae Y.S. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem. Biophys. Res. Commun. 330 (2005) 989-998
8. Mullan R.H., Bresnihan B., Golden-Mason L., Markham T., O'hara R., Fitzgerald O., Veale D.J., and Fearon U. Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis. Rheum. 54 (2006) 105-114
9. Furlaneto C.J., and Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 268 (2000) 405-408
10. Jijon H.B., Madsen K.L., Walker J.W., Allard B., and Jobin C. Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur. J. Immunol. 35 (2005) 718-726
11. Dano K., Behrendt N., Hoyer-Hansen G., Johnsen M., Lund L.R., Ploug M., and Romer J. Plasminogen activation and cancer. Thromb. Haemost. 93 (2005) 676-681
12. Sidenius N., and Blasi F. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev. 22 (2003) 205-222
13. Urieli-Shoval S., Shubinsky G., Linke R.P., Fridkin M., Tabi I., and Matzner Y. Adhesion of human platelets to serum amyloid A. Blood 99 (2002) 1224-1229
14. Linke R.P. Monoclonal antibodies against amyloid fibril protein AA. Production, specificity and use for immunohistochemical localization and classification of AA-type amyloidosis. J. Histochem. Cytochem. 32 (1984) 322-328
15. Deutsch D.G., and Mertz E.T. Plasminogen: purification from human plasma by affinity chromatography. Science 170 (1970) 1095-1096
16. Castello R., Estelles A., Vazquez C., Falco C., Espana F., Almenar S.M., Fuster C., and Aznar J. Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer. Clin. Chem. 48 (2002) 1288-1295
17. Iwamoto J., Mizokami Y., Takahashi K., Nakajima K., Ohtsubo T., Miura S., Narasaka T., Takeyama H., Omata T., Shimokobe K., Ito M., Takehara H., and Matsuoka T. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. Scand. J. Gastroenterol. 40 (2005) 783-793
18. Hochner-Celnikier D., Greenfield C., Finci-Yeheskel Z., Milwidsky A., Gutman A., Goldman-Wohl D., Yagel S., and Mayer M. Tamoxifen exerts oestrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of oestrogen-responsive human endometrial adenocarcinoma cells. Mol. Hum. Reprod. 12 (1997) 1019-1027
19. Milwidsky A., Finci-Yeheskel Z., and Mayer M. Stimulation of plasmin activity by aspirin. Thromb. Haemost. 65 (1991) 389-393
20. Buo L., Bjornland K., Karlsrud T.S., Kvale D., Kjonniksen I., Fodstad O., Brandtzaeg P., Johansen H.T., and Aasen A.O. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines. Anticancer Res. 14 (1994) 2445-2452
21. Karlan B.Y., Amin W., Band V., Zurawski V.R., and Littlefield B.A. Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro. Gynecol. Oncol. 31 (1988) 103-112
22. Bobbink I.W., Tekelenburg W.L., Sixma J.J., de Boer H.C., Banga J.D., and de Groot P.G. Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation. Biochem. Biophys. Res. Commun. 240 (1997) 595-601
23. Jiang S.L., Lozanski G., Samols D., and Kushner I. Induction of human serum amyloid A in Hep3B cells by IL-6 and IL-1 beta involves both transcriptional and post-transcriptional mechanisms. J. Immunol. 154 (1995) 825-831
24. De Bruin P.A., Griffioen G., Verspaget H.W., Verheijen J.H., Dooijewaard G., van den Ingh H.F., and Lamers C.B. Plasminogen activator profiles in neoplastic tissues of the human colon. Cancer Res. 48 (1988) 4520-4524
25. Suzuki S., Hayashi Y., Wang Y., Nakamura T., Morita Y., Kawasaki K., Ohta K., Aoyama N., Kim S.R., Itoh H., Kuroda Y., and Doe W.F. Urokinase type plasminogen activator receptor expression in colorectal neoplasms. Gut 43 (1998) 798-805
26. Harvey S.R., Sait S.N.J., Xu Y., Bailey J.L., Penetrante R.M., and Markus G. Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization. Am. J. Pathol. 155 (1999) 1115-1120